B
WST icon

Barings’s West Pharmaceutical WST Stock Holding History

Barings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-541
Closed -$207K – 179
2023
Q2 		$207K Buy
+541
New +$193K 0.01% 160
2020
Q4 		– Sell
-5,048
Closed -$1.39M – 636
2020
Q3 		$1.39M Sell
5,048
-5,982
-54% -$1.58M 0.03% 291
2020
Q2 		$1.68M Hold
11,030
– – 0.06% 215
2020
Q1 		$1.68M Hold
11,030
– – 0.06% 215
2019
Q4 		$1.66M Hold
11,030
– – 0.04% 271
2019
Q3 		$1.56M Hold
11,030
– – 0.04% 286
2019
Q2 		$1.38M Buy
11,030
+7,930
+256% +$936K 0.03% 325
2019
Q1 		$342K Hold
3,100
– – 0.01% 601
2018
Q4 		$304K Sell
3,100
-22,965
-88% -$2.49M 0.01% 594
2018
Q3 		$3.22M Buy
26,065
+13,050
+100% +$1.46M 0.05% 248
2018
Q2 		$1.29M Sell
13,015
-6,870
-35% -$632K 0.02% 455
2018
Q1 		$1.76M Hold
19,885
– – 0.03% 392
2017
Q4 		$1.96M Sell
19,885
-1,215
-6% -$119K 0.03% 393
2017
Q3 		$2.03M Hold
21,100
– – 0.04% 313
2017
Q2 		$1.99M Sell
21,100
-18,831
-47% -$1.73M 0.06% 310
2017
Q1 		$3.26M Buy
39,931
+17,831
+81% +$1.49M 0.07% 232
2016
Q4 		$1.88M Hold
22,100
– – 0.05% 285
2016
Q3 		$1.65M Buy
22,100
+1,000
+5% +$79.4K 0.04% 324
2016
Q2 		$1.6M Hold
21,100
– – 0.04% 361
2016
Q1 		$1.46M Hold
21,100
– – 0.04% 384
2015
Q4 		$1.27M Buy
21,100
+9,800
+87% +$590K 0.03% 422
2015
Q3 		$612K Buy
11,300
+6,800
+151% +$396K 0.02% 577
2015
Q2 		$261K Buy
+4,500
New +$251K 0.01% 854

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Barings's WST Position: Q3 2023 in Review

Barings sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 541 shares — an estimated $207K sold.

Barings first reported a position in WST in Q2 2015 and held it in 23 quarters. The position peaked at $3.26M in Q1 2017. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Barings reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Barings sold 541 West Pharmaceutical shares in Q3 2023, an estimated $207K.
  • Barings first reported a position in West Pharmaceutical in Q2 2015 and held it in 23 quarters.
  • Barings's West Pharmaceutical position peaked at $3.26M in Q1 2017.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Barings's 13F filing for Q3 2023, filed 13 Nov 2023.